All lobbying filings
Venable LLP
Venable LLP filed a Q3 report for Geneoscopy on October 8, 2025, reporting $30,000 in lobbying income.
Lobbying for Geneoscopy · Life sciences company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 8, 2025
Income
$30,000
What the client paid this registrant for the period.
Client based in
Missouri
Government bodies contacted
2
Lobbying activity
2
Increasing access to colorectal cancer screening; Medicare coverage of colorectal cancer screening tests; USPSTF colorectal cancer screening guidelines; Medicare Quality Measures
FY 2026 VA Appropriations Expanding colorectal cancer screening for veterans